4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-016040
EVP, General Counsel returned 3,825 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Howton David T · EVP, General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-28 | Returned to the company : show line 1 in the form | −3,825 | 15,746 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-04 | Grant or award : show line 2 in the form Stock option (right to buy) | +45,000 | $145.48 | 2029-03-04 | 45,000 | 45,000 | D |
Loading xslF345X03/doc4.xml…